AVXL financials
Anavex Life Sciences (AVXL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AVXL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$51.41M | -$46.38M | -0.54 |
| 2024 | – | – | -$52.88M | -$43.00M | -0.52 |
| 2023 | – | – | -$55.76M | -$47.51M | -0.60 |
| 2022 | – | – | -$50.99M | -$47.98M | -0.62 |
| 2021 | – | – | -$42.00M | -$37.91M | -0.54 |
| 2020 | – | – | -$31.09M | -$26.28M | -0.45 |